TIRADS 1 and TIRADS 2: When Your Ultrasound Results Are Telling You There Is Minimal Risk
Written by John P. Sabra, MD FACS
Updated September 2026
Educational only. This article is not medical advice. Always consult your physician about your individual situation.
Not every Ultrasound TIRADS result is a problem. TIRADS 1 and TIRADS 2 are the reassuring categories at the bottom of the scale. They mean the ultrasound found nothing that looks suspicious, and they generally do not require biopsy. Understanding what these categories actually tell you, and what little follow-up is usually needed, is the difference between needless anxiety and an appropriate next step.
TIRADS, the Thyroid Imaging Reporting and Data System, is a five-tier classification system developed by the American College of Radiology to standardize how thyroid ultrasound findings are reported. It runs from TR1 (normal or benign) to TR5 (highly suspicious for cancer). The two lowest categories, TR1 and TR2, describe nodules or findings that do not raise concern for malignancy.
A TR1 or TR2 result is one of the most reassuring things an ultrasound report can say. The malignancy risk associated with TR1 is essentially 0%. The risk for TR2 is under 2%. Biopsy is generally not recommended for either category, regardless of nodule size.
What TR1 Means
TR1 means the ultrasound either found no nodule or found findings that are clearly benign. Examples include a normal thyroid with no nodules, a simple thyroid cyst (a small fluid-filled sac with no solid component), or a spongiform nodule pattern (a benign appearance with multiple tiny cystic spaces). These findings have an established benign character on imaging and do not require biopsy.
A TR1 nodule does not need surveillance the way higher-risk nodules do. For simple cysts and spongiform nodules, monitoring is not generally recommended unless the nodule is causing symptoms or has grown noticeably.
What TR2 Means
TR2 indicates a non-suspicious nodule. The ultrasound features are predominantly benign-appearing but do not quite meet the criteria for TR1. Examples include mostly-cystic nodules with a small amount of solid tissue, hyperechoic (bright) nodules without suspicious features, and certain patterns of multinodular thyroid tissue. The malignancy risk for TR2 is under 2%, similar to the risk of finding cancer in a thyroid that has not been imaged at all.
⚕ Clinical note: The TIRADS thresholds for biopsy are deliberately set higher for low-suspicion nodules because biopsying every nodule found by ultrasound would generate enormous numbers of biopsies, many of them uninformative and a small number of them leading to unnecessary surgery for benign disease. The TIRADS system is built to focus biopsy on nodules where the answer is most likely to matter.
Biopsy Thresholds for TR1 and TR2
| Category | Malignancy Risk | Biopsy Recommendation |
|---|---|---|
| TR1 (benign) | Essentially 0% | Not recommended. |
| TR2 (not suspicious) | Under 2% | Not recommended at any size by current ACR guidelines. |
When Follow-Up Imaging Makes Sense
For a TR1 finding, no specific follow-up is generally recommended. For a TR2 nodule, the ACR recommends one follow-up ultrasound in 1 to 2 years if the nodule is 2.5 cm or larger. If the nodule is stable on follow-up, no further imaging is needed. Follow up may be recommended by your doctor regardless of TIRADS results based on size or family history, or professional preference.
-
Simple cyst (TR1): No surveillance needed unless symptomatic.
-
Spongiform nodule (TR1): No surveillance needed unless growing or causing symptoms.
-
TR2 under 2.5 cm: No surveillance needed. (physician preference may indicate)
-
TR2 of 2.5 cm or larger: One follow-up ultrasound at 12 to 24 months.
When to Look More Carefully Despite a Low TIRADS
A few clinical situations warrant a closer look at the thyroid even when ultrasound features look reassuring. The TIRADS system is built on imaging features alone and does not incorporate clinical context.
-
Family history of thyroid cancer or MEN syndromes: A genetic predisposition can warrant earlier or more frequent surveillance regardless of TIRADS.
-
Prior radiation exposure to the head or neck: Childhood radiation exposure raises baseline thyroid cancer risk and may prompt closer follow-up.
-
Suspicious-appearing lymph nodes: Abnormal lymph nodes near the thyroid can be a sign of disease even when the thyroid itself looks benign on ultrasound. Lymph node features matter independently.
-
Rapid growth in a previously stable nodule: A nodule that has been TR2 for years and then changes character warrants a fresh look.
⚕ Clinical note: The most important thing a TR1 or TR2 result tells you is that the imaging features themselves are not concerning. It does not mean that thyroid problems can never develop in the future. Any new symptom (visible neck swelling, voice changes, pressure on the airway, swallowing difficulty) warrants reevaluation regardless of past imaging.
The Bottom Line
TR1 and TR2 are the reassuring TIRADS categories. They describe findings that are not suspicious for cancer and do not require biopsy. Most TR1 findings need no surveillance at all. TR2 nodules of 2.5 cm or larger get one follow-up ultrasound; smaller TR2 nodules typically need no further imaging, but your physician may choose to do so. The clinical context still matters, and any new symptoms warrant reevaluation regardless of past imaging results.
If your ultrasound was TR1 or TR2, you do not need to repeat imaging unless your physician recommends it based on size or clinical context, and you can move forward without further evaluation in most cases.
This article is intended for patient education only. It does not constitute medical advice and does not replace a consultation with your physician. Individual patient circumstances and clinical judgment determine the appropriate evaluation and management for every patient.
More from the Ultrasound series
Ready to Talk to a Specialist?
A thyroid specialist can review your specific results, answer your questions, and help you understand exactly what your next steps should be. The ATLAS network connects you with experienced thyroid and parathyroid expert physicians who focus on thyroid disease.
Find a Thyroid Specialist Near You →